Trexquant Investment LP Intra Cellular Therapies, Inc. Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

A detailed history of Trexquant Investment LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 99,549 shares of ITCI stock, worth $12.7 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
99,549
Previous 78,537 26.75%
Holding current value
$12.7 Million
Previous $5.38 Million 35.35%
% of portfolio
0.1%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$67.99 - $80.84 $1.43 Million - $1.7 Million
21,012 Added 26.75%
99,549 $7.28 Million
Q2 2024

Aug 13, 2024
BUY
$64.76 - $79.84 $394,323 - $486,145
6,089 Added 8.4%
78,537 $5.38 Million
Q1 2024

May 14, 2024
SELL
$64.37 - $75.65 $413,770 - $486,278
-6,428 Reduced 8.15%
72,448 $5.01 Million
Q4 2023

Feb 09, 2024
BUY
$46.37 - $73.65 $140,732 - $223,527
3,035 Added 4.0%
78,876 $5.65 Million
Q3 2023

Nov 13, 2023
BUY
$52.09 - $64.1 $1.63 Million - $2 Million
31,255 Added 70.1%
75,841 $3.95 Million
Q2 2023

Aug 11, 2023
BUY
$54.67 - $66.44 $639,256 - $776,882
11,693 Added 35.55%
44,586 $2.82 Million
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $7,402 - $9,631
169 Added 0.52%
32,893 $1.78 Million
Q4 2022

Feb 13, 2023
BUY
$44.07 - $54.45 $1.44 Million - $1.78 Million
32,724 New
32,724 $1.73 Million
Q2 2022

Aug 11, 2022
BUY
$43.0 - $65.64 $359,480 - $548,750
8,360 New
8,360 $477,000
Q3 2021

Nov 12, 2021
SELL
$28.72 - $42.49 $441,311 - $652,901
-15,366 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$29.3 - $44.5 $450,223 - $683,787
15,366 New
15,366 $627,000
Q2 2020

Aug 07, 2020
SELL
$14.35 - $26.64 $573,799 - $1.07 Million
-39,986 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$12.31 - $33.12 $492,227 - $1.32 Million
39,986 New
39,986 $615,000
Q4 2019

Feb 12, 2020
SELL
$7.26 - $38.49 $133,460 - $707,561
-18,383 Closed
0 $0
Q3 2019

Nov 08, 2019
BUY
$7.47 - $14.03 $137,321 - $257,913
18,383 New
18,383 $137,000
Q3 2018

Nov 09, 2018
SELL
$17.77 - $22.9 $250,485 - $322,798
-14,096 Closed
0 $0
Q2 2018

Aug 07, 2018
SELL
$17.33 - $23.4 $63,843 - $86,205
-3,684 Reduced 20.72%
14,096 $249,000
Q1 2018

May 03, 2018
SELL
$15.16 - $25.49 $294,452 - $495,092
-19,423 Reduced 52.21%
17,780 $374,000
Q4 2017

Feb 09, 2018
BUY
$14.27 - $16.79 $71,735 - $84,403
5,027 Added 15.62%
37,203 $539,000
Q3 2017

Nov 09, 2017
BUY
$10.77 - $22.1 $346,535 - $711,089
32,176
32,176 $508,000

Others Institutions Holding ITCI

# of Institutions
383
Shares Held
85M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email